Embolization of prostatic arteries to stop bleeding in prostate cancer

Abstract

Prostatic bleeding is life-threatening, and its most common cause is locally advanced prostate cancer. In several patients, hemostatic therapy is ineffective. Surgery is not feasible in most patients owing to the high surgical risk. In such cases, prostatic artery embolization may be the method of choice to stop the bleeding. This procedure is minimally invasive; thus, it can be performed in patients with contraindications to more extensive operations. Despite limited experience with embolization of prostatic arteries, according to the literature, it is effective in 90% of treated patients. This article provides a review of the literature and clinical observations of the successful use of prostatic artery embolization to stop bleeding in patients with locally advanced prostate cancer.

Keywords

embolization of prostatic arteries / bleeding / prostate cancer

References

[1] Somov AN, Suslin SA. Prostate cancer. Epidemiology, risk factors and early detection. Russian journal of preventive medicine and public health. 2020;23(3):149–155. EDN: GZQTTB doi: 10.17116/profmed202023031149

[2] Сомов А.Н., Суслин С.А. Рак предстательной железы. Эпидемиология, факторы риска и раннее выявление // Профилактическая медицина. 2020. Т. 23, № 3. С. 149–155. EDN: GZQTTB doi: 10.17116/profmed202023031149

[3] Karpov YeI. Prophylaxis of prostate cancer: current status of the problem. Effective pharmacotherapy. Urology and nephrology. 2015;(3):32–37. EDN: OBBMNL

[4] Карпов Е.И. Профилактика рака предстательной железы: современное состояние проблемы // Эффективная фармакотерапия. Урология и нефрология. 2015. № 3. С. 32–37. EDN: OBBMNL

[5] Khvastunov RA. Prostate cancer. Journal of Volgograd State Medical University. 2008;(3):3–8. EDN: JSKERB

[6] Хвастунов Р.А. Рак предстательной железы // Вестник Волгоградского государственного медицинского университета. 2008. № 3. С. 3–8. EDN: JSKERB

[7] Chen J-W, Shin JH, Tsao T-F, et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28(2):295–301. doi: 10.1016/j.jvir.2016.10.010

[8] Chen J.-W., Shin J.H., Tsao T.-F., et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer // J Vasc Interv Radiol. 2017. Vol. 28, N 2. P. 295–301. doi: 10.1016/j.jvir.2016.10.010

[9] Pereira K, Halpern JA, McClure TD, et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(3):359–365. doi: 10.1111/bju.13524

[10] Pereira K., Halpern J.A., McClure T.D., et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin // BJU Int. 2016. Vol. 118, N 3. P. 359–365. doi: 10.1111/bju.13524

[11] Gorelov DS, Gadzhiev NK, Ovcharenko DV, et ap. Prostatic artery embolisation in treatment of benign prostatic hyperplasia. Urology and Andrology. 2018;6(3):38–42. EDN: YVXAGL doi: 10.20953/2307-6631-2018-3-38-42

[12] Горелов Д.С., Гаджиев Н.К., Овчаренко Д.В., и др. Эмболизация простатических артерий в лечении доброкачественной гиперплазии предстательной железы // Вопросы урологии и андрологии. 2018. Т. 6, № 3. С. 38–42. EDN: YVXAGL doi: 10.20953/2307-6631-2018-3-38-42

[13] Shim SR, Kanhai KJ, Ko YM, Kim JH. Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression. J Urol. 2017;197(2):465–479. doi: 10.1016/j.juro.2016.08.100

[14] Shim S.R., Kanhai K.J., Ko Y.M., Kim J.H. Efficacy and safety of prostatic arterial embolization: systematic review with meta-analysis and meta-regression // J Urol. 2017. Vol. 197, N 2. P. 465–479. doi: 10.1016/j.juro.2016.08.100

[15] Korkmaz M, Şanal B, Aras B, et al. The short- and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria. Diagn Interv Imaging. 2016;97(2):197–201. doi: 10.1016/j.diii.2015.06.020

[16] Korkmaz M., Şanal B., Aras B., et al. The short- and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria // Diagn Interv Imaging. 2016. Vol. 97, N 2. P. 197–201. doi: 10.1016/j.diii.2015.06.020

[17] Loffroy R, Pottecher P, Cherblanc V, et al. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage. Diagn Interv Imaging. 2014;95(11):1027–1034. doi: 10.1016/j.diii.2014.03.008

[18] Loffroy R., Pottecher P., Cherblanc V., et al. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage // Diagn Interv Imaging. 2014. Vol. 95, N 11. P. 1027–1034. doi: 10.1016/j.diii.2014.03.008

[19] Carmignani G, Belgrano E, Puppo P, et al. Transcatheter embilization of the hypogastric arteries in cases of bladder hemorrhage from advanced pelvic cancers: follow up in 9 cases. J Urol. 1980;124(2):196–200. doi: 10.1016/s0022-5347(17)55371-9

[20] Carmignani G., Belgrano E., Puppo P., et al. Transcatheter embilization of the hypogastric arteries in cases of bladder hemorrhage from advanced pelvic cancers: follow up in 9 cases // J Urol. 1980. Vol. 124, N 2. P. 196–200. doi: 10.1016/s0022-5347(17)55371-9

[21] Appleton DS, Sibley GNA, Doyle PT. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol. 1988;61(1):45–47. doi: 10.1111/j.1464-410x.1988.tb09160.x

[22] Appleton D.S., Sibley G.N.A., Doyle P.T. Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage // Br J Urol. 1988. Vol. 61, N 1. P. 45–47. doi: 10.1111/j.1464-410x.1988.tb09160.x

[23] Pisco JM, Martins JM, Correia MG. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms. Radiology. 1989;172(2):337–339. doi: 10.1148/radiology.172.2.2748811

[24] Pisco J.M., Martins J.M., Correia M.G. Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms // Radiology. 1989. Vol. 172, N 2. P. 337–339. doi: 10.1148/radiology.172.2.2748811

[25] Sieber PR. Bladder necrosis secondary to pelvic artery embolization: case report and literature review. J Urol. 1994;151(2):422. doi: 10.1016/s0022-5347(17)34969-8

[26] Sieber P.R. Bladder necrosis secondary to pelvic artery embolization: case report and literature review // J Urol. 1994. Vol. 151, N 2. P. 422. doi: 10.1016/s0022-5347(17)34969-8

[27] Rastinehad AR, Caplin DM, Ost MC, et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. 2008;71(2):181–184. doi: 10.1016/j.urology.2007.09.012

[28] Rastinehad A.R., Caplin D.M., Ost M.C., et al. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin // Urology. 2008. Vol. 71, N 2. P. 181–184. doi: 10.1016/j.urology.2007.09.012

[29] Delgal A, Cercueil J-P, Koutlidis N, et al. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage. J Urol. 2010;183(5):1947–1953. doi: 10.1016/j.juro.2010.01.003

[30] Delgal A., Cercueil J.-P., Koutlidis N., et al. Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage // J Urol. 2010. Vol. 183, N 5. P. 1947–1953. doi: 10.1016/j.juro.2010.01.003

[31] Prasad V, Sacks BA, Kraus S, Clouse ME. Embolotherapy for lower urinary tract hemorrhage. J Vasc Interv Radiol. 2009;20(7): 965–970. doi: 10.1016/j.jvir.2009.04.048

[32] Prasad V., Sacks B.A., Kraus S., Clouse M.E. Embolotherapy for lower urinary tract hemorrhage // J Vasc Interv Radiol. 2009. Vol. 20, N 7. P. 965–970. doi: 10.1016/j.jvir.2009.04.048

[33] Cizman Z, Isaacson A, Burke C. Short- to midterm safety and efficacy of prostatic artery embolization: A systematic review. J Vasc Interv Radiol. 2016;27(10):1487–1493.e1. doi: 10.1016/j.jvir.2016.04.015

[34] Cizman Z., Isaacson A., Burke C. Short- to midterm safety and efficacy of prostatic artery embolization: A systematic review // J Vasc Interv Radiol. 2016. Vol. 27, N 10. P. 1487–1493.e1. doi: 10.1016/j.jvir.2016.04.015

RIGHTS & PERMISSIONS

Eco-Vector